Mechanistically, targeting PGAM1 restrains HCC growth by suppressing LCN2 and PD‐L1 expression via energy stress/ROS‐dependent inhibition of AKT and potentiates robust CD8+ T‐cell infiltration. The gene discussed is CD8A; the disease is hepatocellular carcinoma.